AU4575897A - Pharmaceutical and diagnostic use of serum amyloid p component - Google Patents

Pharmaceutical and diagnostic use of serum amyloid p component

Info

Publication number
AU4575897A
AU4575897A AU45758/97A AU4575897A AU4575897A AU 4575897 A AU4575897 A AU 4575897A AU 45758/97 A AU45758/97 A AU 45758/97A AU 4575897 A AU4575897 A AU 4575897A AU 4575897 A AU4575897 A AU 4575897A
Authority
AU
Australia
Prior art keywords
pharmaceutical
component
serum amyloid
diagnostic use
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45758/97A
Inventor
Cornelis Petrus Maria Van Kessel
Johannes Antonius Gerardus Van Strijp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rijksuniversiteit Utrecht
Original Assignee
Rijksuniversiteit Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL1004258A external-priority patent/NL1004258C2/en
Application filed by Rijksuniversiteit Utrecht filed Critical Rijksuniversiteit Utrecht
Publication of AU4575897A publication Critical patent/AU4575897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/579—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
AU45758/97A 1996-10-11 1997-10-10 Pharmaceutical and diagnostic use of serum amyloid p component Abandoned AU4575897A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NL1004258A NL1004258C2 (en) 1996-10-11 1996-10-11 New peptide(s) from serum amyloid P for neutralising lipo-polysaccharide
NL1004258 1996-10-11
NL1006583 1997-07-14
NL1006583 1997-07-14
PCT/NL1997/000567 WO1998016556A1 (en) 1996-10-11 1997-10-10 Pharmaceutical and diagnostic use of serum amyloid p component

Publications (1)

Publication Number Publication Date
AU4575897A true AU4575897A (en) 1998-05-11

Family

ID=26642453

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45758/97A Abandoned AU4575897A (en) 1996-10-11 1997-10-10 Pharmaceutical and diagnostic use of serum amyloid p component

Country Status (3)

Country Link
EP (1) EP0932624A1 (en)
AU (1) AU4575897A (en)
WO (1) WO1998016556A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
DK0915707T3 (en) * 1996-01-25 2003-03-03 Profylakse Aps Pharmaceutical compositions comprising serum amyloid P component for prophylactic or therapeutic treatment of viral infections and kits for detecting the binding of compositions to viral components
US6365570B1 (en) * 1997-10-10 2002-04-02 Universiteit Utrecht Pharmaceutical and diagnostic use of Serum Amyloid P component
NL1009045C2 (en) * 1998-04-29 1999-11-01 Univ Utrecht Peptide with endotoxin neutralizing activity.
CN112742067B (en) * 2020-12-14 2022-07-05 广州博仁安康医疗科技有限公司 Method for removing endotoxin from fetal calf serum

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5092876A (en) * 1989-08-30 1992-03-03 The United States Of America As Represented By The Department Of Health And Human Services Cell attachment peptides derived from amyloid P component
US5405832A (en) * 1991-11-27 1995-04-11 Immtech International Inc. Method of treating non-streptococcal bacterial infections
GB9317120D0 (en) * 1993-08-17 1993-09-29 Royal Postgrad Med School Human serum amyloid p component
DK0915707T3 (en) * 1996-01-25 2003-03-03 Profylakse Aps Pharmaceutical compositions comprising serum amyloid P component for prophylactic or therapeutic treatment of viral infections and kits for detecting the binding of compositions to viral components

Also Published As

Publication number Publication date
WO1998016556A1 (en) 1998-04-23
EP0932624A1 (en) 1999-08-04

Similar Documents

Publication Publication Date Title
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU1618697A (en) Novel compounds and pharmaceutical use thereof
GB9317120D0 (en) Human serum amyloid p component
AU4597596A (en) Prevention of protein aggregation
AU7373694A (en) Medical connection indicator and method of use
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
AU4749297A (en) Therapeutic and diagnostic applications of laminin and laminin-derived protein fragments
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
AU6184396A (en) Solid oral diagnostic test meal and methods of use thereof
AU2749395A (en) Medical use of bromelain
AU5252698A (en) Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
AU4236297A (en) Therapeutic and diagnostic applications of perlecan domain splice variants
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
AU7852594A (en) Device for dismantling and particularly draining of vehicles
AU7042796A (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
AU4006695A (en) Calcineurin interacting protein compositions and methods
AU2667197A (en) Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits
AU2989495A (en) Separation of human serum albumin
AU4575897A (en) Pharmaceutical and diagnostic use of serum amyloid p component
AU4123396A (en) Cephem compounds and pharmaceutical use thereof
EP1057492B8 (en) Blood-compatible composition and medical device using same
AU7141698A (en) Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
AU7260098A (en) Diagnosis and treatment of phosphatase 0r kinase-related disorders
AU4036495A (en) Device and test kit for the detection of AIDS